March 23, 2020 / 9:52 PM / 5 days ago

BRIEF-Gilead Granted Orphan Drug Label For Potential Coronavirus Treatment

March 23 (Reuters) - Gilead Sciences Inc:

* U.S. FDA - GILEAD GRANTED ORPHAN DRUG DESIGNATION FOR POTENTIAL CORONAVIRUS TREATMENT REMDESIVIR Source text: (bit.ly/2UyzAHM) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below